BCAL Diagnostics Limited (ASX:BDX)
Australia flag Australia · Delayed Price · Currency is AUD
0.1200
+0.0050 (4.35%)
Feb 5, 2026, 10:44 AM AEST

BCAL Diagnostics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
4223391517-
Market Cap Growth
24.23%-41.31%164.34%-10.45%--
Enterprise Value
40173685-
Last Close Price
0.120.060.130.070.08-
PS Ratio
15.978.7012.905.3323.09-
PB Ratio
6.803.714.572.851.72-
P/TBV Ratio
6.823.724.602.851.72-
EV/Sales Ratio
15.166.5511.742.887.25-
Debt / Equity Ratio
0.380.380.180.20--
Asset Turnover
0.240.240.300.290.100.11
Quick Ratio
2.292.293.572.5910.917.15
Current Ratio
2.322.323.602.7411.007.86
Return on Equity (ROE)
-97.79%-97.79%-92.74%-68.16%-51.11%-75.39%
Return on Assets (ROA)
-39.67%-39.67%-36.82%-31.56%-25.88%-23.57%
Return on Capital Employed (ROCE)
-103.50%-103.50%-62.90%-78.30%-31.60%-25.90%
Earnings Yield
-17.11%-31.41%-16.29%-34.06%-20.40%-
FCF Yield
-16.36%-30.03%-14.44%-43.13%-19.55%-
Buyback Yield / Dilution
-46.04%-46.04%-16.75%-3.24%-51.65%-17.28%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.